Progesteron za preprečevanje prezgodnjega poroda
Authors:
Open Access
- 6 October 2015
- journal article
- Published by Slovenian Medical Association in Slovenian Medical Journal
- Vol. 84 (9)
Abstract
Background: Progesterone is important in maintaining pregnancy. Progesterone supplementation may reduce risk of preterm birth in certain populations of pregnant women. The objective of this review was to develop evidence-based clinical recommendation for progesterone treatment in the prevention of preterm birth.Methods: A search in the Medline database was performed using keywords: progesterone, pregnancy, preterm birth, preterm labour, preterm delivery, randomized trial, and randomized controlled trial. We only included studies of vaginal progesterone treatments for the prevention of preterm birth and excluded studies on 17-α-hydroksiprogesterone caproate.Results: We report findings from twelve randomized trials conducted since 2003. These trials differ regarding inclusion criteria, progesterone dose, vehicle used, and duration of treatment. Inclusion criteria were: short uterine cervix (two trials), history of previous preterm birth (two trials), signs and symptoms of preterm labour (three trials), twin pregnancies (three trials), and multiple risk factors (among these history of previous preterm birth was the most common) (two trials). Six of these twelve trials showed a significant reduction in preterm birth in the progesterone groups.Conclusions: Based on current evidence we recommend treatment with 200 mg of micronized progesterone daily, administered vaginally, in pregnant women found to have a short cervix (≤ 25 mm) at 19-24 weeks. The treatment should be continued until 37 weeks.Keywords
This publication has 32 references indexed in Scilit:
- Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo‐controlled trial on the effect of vaginal micronized progesteroneUltrasound in Obstetrics & Gynecology, 2011
- Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double‐blind, placebo‐controlled trialUltrasound in Obstetrics & Gynecology, 2011
- RETRACTED ARTICLE: Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trialArchives of Gynecology and Obstetrics, 2010
- Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double‐blind, placebo‐controlled trialUltrasound in Obstetrics & Gynecology, 2007
- Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: A 2005 follow-up surveyAmerican Journal of Obstetrics and Gynecology, 2006
- Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth2006
- The use of micronized progesterone in the treatment of menace of preterm deliveryEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1991
- Embryotoxicity of sex steroidal hormones in nonhuman primates: II. Hydroxyprogesterone caproate, estradiol valerateTeratology, 1987
- The effects of oral administration of progesterone for premature laborAmerican Journal of Obstetrics and Gynecology, 1986
- Treatment of threatened premature labor with large doses of progesteroneAmerican Journal of Obstetrics and Gynecology, 1960